<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>9d88ff26-f7f6-42b0-b270-ef801e51719c</id>
  <name>AHS OSN CH LAMOTRIGINE NEUROLOGY</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;When using the Pediatric Lamotrigine&amp;nbsp;Smart Set prescribers are required to add:&lt;/p&gt;&lt;ol&gt;&lt;li&gt;Exceptional Care Plan Flag&amp;nbsp;&lt;/li&gt;&lt;li&gt;Complete titration calender within&amp;nbsp;the Patient Instructions section&amp;nbsp;to ensure appropriate medication administration is followed upon discharge.&amp;nbsp;Please us&amp;nbsp;one of these smart phrases:&amp;nbsp;&lt;/li&gt;&lt;/ol&gt;&lt;ul&gt;&lt;li&gt;.&amp;lt;smartphrase&amp;gt;&lt;/li&gt;&lt;li&gt;.&amp;lt;smartphrase&amp;gt;&lt;/li&gt;&lt;li&gt;.&amp;lt;smartphrase&amp;gt;&lt;/li&gt;&lt;/ul&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;LESS than 24 months old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid or nonenzyme-indusing antiseizure medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 1 and 2&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Recommended Dosing:&amp;nbsp;0.15mg/kg/day for 14 days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;LESS than 24 months old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid or nonenzyme-indusing antiseizure medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 1 and 2&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 0.15mg/kg/day Twice a Day for 14 days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;LESS than 24 months old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid or nonenzyme-indusing antiseizure medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 3 and 4&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Recommended Dosing: 0.3mg/kg/day for 14 Days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;LESS than 24 months old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid or nonenzyme-indusing antiseizure medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 3 and 4&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 14 Days&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 0.3 mg/kg/day Twice a Day for 14 days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;LESS than 24 months old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid or nonenzyme-indusing antiseizure medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance Dose&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;titrate dose to effect; after week 4, increase dose every week by no more than 0.3 mg/kg/day; maximum maintenance daily dose: 5.1 mg/kg/&lt;strong&gt;day&lt;/strong&gt;&amp;nbsp;in 3 divided doses not to exceed 200 mg/&lt;strong&gt;day&lt;/strong&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;LESS than 24 months old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid or nonenzyme-indusing antiseizure medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance Dose&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 0.6 mg/kg/day Twice a Day for 14 days&lt;/p&gt;</value>
      </item>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 28 Days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;LESS than 24 months old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving enzyme-inducing antiseizure drug regimens (eg, carbamazepine, phenytoin, phenobarbital, primidone) without valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Week 1 and 2&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 0.6 mg/kg/day, Twice a day for 14 Days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;LESS than 24 months old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving enzyme-inducing antiseizure drug regimens (eg, carbamazepine, phenytoin, phenobarbital, primidone) without valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Week 3 and 4&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 14 Days&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 1.2 mg/kg/day, Twice a day for 14 Days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;LESS than 24 months old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving enzyme-inducing antiseizure drug regimens (eg, carbamazepine, phenytoin, phenobarbital, primidone) without valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;itrate dose to effect; after week 4, increase dose every week by no more than 1.2 mg/kg/day; maximum maintenance daily dose: 15.6 mg/kg/&lt;strong&gt;day&lt;/strong&gt;&amp;nbsp;in 3 divided doses not to exceed 400 mg/&lt;strong&gt;day&lt;/strong&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;LESS than 24 months old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving enzyme-inducing antiseizure drug regimens (eg, carbamazepine, phenytoin, phenobarbital, primidone) without valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 2.4&amp;nbsp;mg/kg/day, Three times a day for 7&amp;nbsp;Days&lt;/p&gt;</value>
      </item>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 28 Days&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;strong&gt;Only whole tablets should be used for dosing&lt;/strong&gt;; children 2 to 6 years will likely require maintenance doses at the higher end of recommended range; patients weighing &amp;lt;30 kg may need as much as a 50% increase in maintenance dose compared with patients weighing &amp;gt;30 kg; titrate dose to clinical effect.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drugs other than carbamazepine, phenytoin, phenobarbital, primidone, or valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 1 and 2&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;0.3 mg/kg/day in 1 to 2 divided doses; round dose down to the nearest whole tablet for 14 Days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drugs other than carbamazepine, phenytoin, phenobarbital, primidone, or valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 1 and 2&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lamoTRIgine chewable tablet&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 0.3 mg/kg/day in 1 to 2 divided doses; round dose down to the nearest whole tablet For 14 Days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drugs other than carbamazepine, phenytoin, phenobarbital, primidone, or valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 1 and 2&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lamoTRIgine tablet&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 0.3 mg/kg/day in 1 to 2 divided doses; round dose down to the nearest whole tablet For 14 Days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drugs other than carbamazepine, phenytoin, phenobarbital, primidone, or valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 3 and 4&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;0.6 mg/kg/day in 2 divided doses; round dose down to the nearest whole tablet, for 14 Days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drugs other than carbamazepine, phenytoin, phenobarbital, primidone, or valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 3 and 4&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lamoTRIgine chewable tablet&apos;]/activities[at0001]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 14 Days&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 0.6 mg/kg/day in 2 divided doses; round dose down to the nearest whole tablet for 14 Days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drugs other than carbamazepine, phenytoin, phenobarbital, primidone, or valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 3 and 4&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lamoTRIgine tablet&apos;]/activities[at0001]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 14 Days&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 0.6 mg/kg/day in 2 divided doses; round dose down to the nearest whole tablet&amp;nbsp;for 14 Days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drugs other than carbamazepine, phenytoin, phenobarbital, primidone, or valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance Dose&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Titrate dose to effect; after week 4, increase dose every 1 to 2 weeks by a calculated increment; calculate increment as 0.6 mg/kg/day rounded down to the nearest whole tablet; add this amount to the previously administered daily dose; usual maintenance: 4.5 to 7.5 mg/kg/day in 2 divided doses; maximum daily dose: 300 mg/&lt;strong&gt;day&lt;/strong&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drugs other than carbamazepine, phenytoin, phenobarbital, primidone, or valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance Dose&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lamoTRIgine chewable tablet&apos;]/activities[at0001]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 28&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral 1.2 mg/kg/day in 2 divided doses; round dose down to the nearest whole tablet for 7&amp;nbsp;Days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drugs other than carbamazepine, phenytoin, phenobarbital, primidone, or valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance Dose&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lamoTRIgine tablet&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 1.2 mg/kg/day in 2 divided doses; round dose down to the nearest whole tablet for 7&amp;nbsp;Days&lt;/p&gt;</value>
      </item>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 28&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation:&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Recommended to use 2 mg every other day for patients weighing GREATER THAN 6.7 kg and LESS THAN 14 kg.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 1 and 2&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;0.15 mg/kg/day&amp;nbsp;in 1 to 2 divided doses for 14 Days.&amp;nbsp;Please note: round dose down to the nearest whole tablet&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 1 and 2&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lamoTRIgine chewable tablet&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral 0.15 mg/kg/day&amp;nbsp;in 2 divided doses for 14 Days.&amp;nbsp;&lt;/p&gt;&lt;p&gt;Please note: round dose down to the nearest whole tablet&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 1 and 2&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lamoTRIgine tablet&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 0.15 mg/kg/day&amp;nbsp;2 divided doses for 14 Days.&amp;nbsp;&lt;/p&gt;&lt;p&gt;Please note: round dose down to the nearest whole tablet&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 3 and 4&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;0.3 mg/kg/day in 1 to 2 divided doses for 14 Days. Please note: round dose down to the nearest whole tablet&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 3 and 4&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lamoTRIgine chewable tablet&apos;]/activities[at0001]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 14 Days&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 0.3 mg/kg/day in 2 divided doses for 14 Days.&lt;/p&gt;&lt;p&gt;Please note: round dose down to the nearest whole tablet.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 3 and 4&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lamoTRIgine tablet&apos;]/activities[at0001]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 14 Days&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 0.3 mg/kg/day in 2 divided doses for 14 Days.&lt;/p&gt;&lt;p&gt;Please note: round dose down to the nearest whole tablet.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance dose&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Titrate dose to effect; after week 4, increase dose every 1 to 2 weeks by a calculated increment; calculate increment as 0.3 mg/kg/day rounded down to the nearest whole tablet; add this amount to the previously administered daily dose; usual maintenance: 1 to 5 mg/kg/day in 1 to 2 divided doses; maximum daily dose: 200 mg/&lt;strong&gt;day&lt;/strong&gt;.&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Note:&lt;/strong&gt;&amp;nbsp;Usual maintenance dose in children adding lamotrigine to valproic acid&amp;nbsp;&lt;strong&gt;alone&lt;/strong&gt;: 1 to 3 mg/kg/day&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance dose&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lamoTRIgine chewable tablet&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 0.6&amp;nbsp;mg/kg/day in 2 divided doses for 7&amp;nbsp;Days.&lt;/p&gt;&lt;p&gt;Please note: round dose down to the nearest whole tablet.&lt;/p&gt;</value>
      </item>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 28 Days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance dose&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lamoTRIgine tablet&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 0.6&amp;nbsp;mg/kg/day in 2 divided doses for 7&amp;nbsp;Days.&lt;/p&gt;&lt;p&gt;Please note: round dose down to the nearest whole tablet.&lt;/p&gt;</value>
      </item>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 28 Days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving enzyme-inducing antiseizure drug regimens (eg, carbamazepine, phenytoin, phenobarbital, primidone) without valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 1 and 2&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lamoTRIgine chewable tablet&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp;Oral: 0.6 mg/kg/day in 2 divided doses for 14 Days, round dose down to the nearest whole tablet.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving enzyme-inducing antiseizure drug regimens (eg, carbamazepine, phenytoin, phenobarbital, primidone) without valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 1 and 2&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lamoTRIgine tablet&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp;Oral: 0.6 mg/kg/day in 2 divided doses for 14 Days, round dose down to the nearest whole tablet.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving enzyme-inducing antiseizure drug regimens (eg, carbamazepine, phenytoin, phenobarbital, primidone) without valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 3 and 4&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lamoTRIgine chewable tablet&apos;]/activities[at0001]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 14 Days&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 1.2 mg/kg/day in 2 divided doses for 14 Days; round dose down to the nearest whole tablet.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving enzyme-inducing antiseizure drug regimens (eg, carbamazepine, phenytoin, phenobarbital, primidone) without valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Initiation:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 3 and 4&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lamoTRIgine tablet&apos;]/activities[at0001]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 14&amp;nbsp;&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 1.2 mg/kg/day in 2 divided doses for 14 Days; round dose down to the nearest whole tablet.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving enzyme-inducing antiseizure drug regimens (eg, carbamazepine, phenytoin, phenobarbital, primidone) without valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance dose&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Titrate dose to effect; after week 4, increase dose every 1 to 2 weeks by a calculated increment; calculate increment as 1.2 mg/kg/day rounded down to the nearest whole tablet; add this amount to the previously administered daily dose; usual maintenance: 5 to 15 mg/kg/day in 2 divided doses; maximum daily dose: 400 mg/&lt;strong&gt;day&lt;/strong&gt;.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving enzyme-inducing antiseizure drug regimens (eg, carbamazepine, phenytoin, phenobarbital, primidone) without valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance dose&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lamoTRIgine chewable tablet&apos;]/activities[at0001]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 28 Days&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral:&amp;nbsp;1.2 mg/kg/day in 2 divided doses for 7 Days rounded down to the nearest whole table&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children 2 - 12 Years Old&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving enzyme-inducing antiseizure drug regimens (eg, carbamazepine, phenytoin, phenobarbital, primidone) without valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance dose&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lamoTRIgine tablet&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral:&amp;nbsp;1.2 mg/kg/day in 2 divided doses for 7 Days rounded down to the nearest whole table&lt;/p&gt;</value>
      </item>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 28&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adolescents (Greater than 12 Years Old)&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Dose increases after week 8 should not exceed 100 mg/day at weekly intervals.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adolescents (Greater than 12 Years Old)&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drugs other than carbamazepine, phenytoin, phenobarbital, primidone, or valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 1 and 2&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp;Oral: 25 mg every day for 14 days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adolescents (Greater than 12 Years Old)&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drugs other than carbamazepine, phenytoin, phenobarbital, primidone, or valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 3 and 4&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 14&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 50 mg every day for 14 Days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adolescents (Greater than 12 Years Old)&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drugs other than carbamazepine, phenytoin, phenobarbital, primidone, or valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Oral: Titrate dose to effect; after week 4, increase dose every 1 to 2 weeks by 50 mg/day; usual maintenance: 225 to 375 mg/day in 2 divided doses.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adolescents (Greater than 12 Years Old)&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drugs other than carbamazepine, phenytoin, phenobarbital, primidone, or valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 100&amp;nbsp;mg every day for 7 Days&lt;/p&gt;</value>
      </item>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 28&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adolescents (Greater than 12 Years Old)&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 1 and 2&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp;Oral: 25 mg every other day for 14 Days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adolescents (Greater than 12 Years Old)&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 3 and 4&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 14&amp;nbsp;&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp;Oral: 25 mg every day for 14 days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adolescents (Greater than 12 Years Old)&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Titrate dose to effect; after week 4, increase dose every 1 to 2 weeks by 25 to 50 mg/day; usual maintenance in patients receiving valproic acid and other drugs that induce glucuronidation: 100 to 400 mg/day in 1 to 2 divided doses; usual maintenance in patients adding lamotrigine to valproic acid&amp;nbsp;&lt;strong&gt;alone&lt;/strong&gt;: 100 to 200 mg/day.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adolescents (Greater than 12 Years Old)&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving antiseizure drug regimens containing valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp;Oral: 50 - 75 mg every day for 7 days&lt;/p&gt;</value>
      </item>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 28&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adolescents (Greater than 12 Years Old)&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving enzyme-inducing antiseizure drug regimens (eg, carbamazepine, phenytoin, phenobarbital, primidone) without valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 1 and 2&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 50 mg/day once daily for 14 Days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adolescents (Greater than 12 Years Old)&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving enzyme-inducing antiseizure drug regimens (eg, carbamazepine, phenytoin, phenobarbital, primidone) without valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Weeks 3 and 4&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 14&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 100 mg/day in 2 divided doses for 14 Days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adolescents (Greater than 12 Years Old)&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving enzyme-inducing antiseizure drug regimens (eg, carbamazepine, phenytoin, phenobarbital, primidone) without valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Titrate dose to effect; after week 4, increase dose every 1 to 2 weeks by 100 mg/day; usual maintenance: 300 to 500 mg/day in 2 divided doses; doses as high as 700 mg/day in 2 divided doses have been used.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adolescents (Greater than 12 Years Old)&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patients receiving enzyme-inducing antiseizure drug regimens (eg, carbamazepine, phenytoin, phenobarbital, primidone) without valproic acid:&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Maintenance&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Oral: 200&amp;nbsp;mg/day in 2 divided doses for 7&amp;nbsp;Days&lt;/p&gt;</value>
      </item>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;S + 28&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]"><items><item><key>Technical.ﻩ Technical Traceability</key><value>{~AHSID~9d88ff26-f7f6-42b0-b270-ef801e51719c~NAME~AHS OSN CH LAMOTRIGINE NEUROLOGY}</value></item></items></annotations><definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Pediatric Neurology Lamotrigine In Patient Order Set">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Lamotrigine Tapers">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="LESS than 24 months old">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Patients receiving antiseizure drug regimens containing valproic acid or nonenzyme-indusing antiseizure medications">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Initiation">
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Weeks 1 and 2">
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d9629066-2292-4c1a-bf2f-18d81195dbc4" concept_name="PHARM lamoTRIgine chewable tablet Compiled Order" max="1" path="/items" name="lamoTRIgine chewable tablet"/>
            </Item>
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Weeks 3 and 4">
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d9629066-2292-4c1a-bf2f-18d81195dbc4" concept_name="PHARM lamoTRIgine chewable tablet Compiled Order" max="1" path="/items" name="lamoTRIgine chewable tablet"/>
            </Item>
          </Item>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Maintenance Dose">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d9629066-2292-4c1a-bf2f-18d81195dbc4" concept_name="PHARM lamoTRIgine chewable tablet Compiled Order" max="1" path="/items" name="lamoTRIgine chewable tablet"/>
          </Item>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Patients receiving enzyme-inducing antiseizure drug regimens (eg, carbamazepine, phenytoin, phenobarbital, primidone) without valproic acid:">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Initiation">
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Week 1 and 2">
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d9629066-2292-4c1a-bf2f-18d81195dbc4" concept_name="PHARM lamoTRIgine chewable tablet Compiled Order" max="1" path="/items" name="lamoTRIgine chewable tablet"/>
            </Item>
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Week 3 and 4">
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d9629066-2292-4c1a-bf2f-18d81195dbc4" concept_name="PHARM lamoTRIgine chewable tablet Compiled Order" max="1" path="/items" name="lamoTRIgine chewable tablet"/>
            </Item>
          </Item>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Maintenance">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d9629066-2292-4c1a-bf2f-18d81195dbc4" concept_name="PHARM lamoTRIgine chewable tablet Compiled Order" max="1" path="/items" name="lamoTRIgine chewable tablet"/>
          </Item>
        </Item>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Children 2 - 12 Years Old">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Patients receiving antiseizure drugs other than carbamazepine, phenytoin, phenobarbital, primidone, or valproic acid:">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Initiation">
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Weeks 1 and 2">
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d9629066-2292-4c1a-bf2f-18d81195dbc4" concept_name="PHARM lamoTRIgine chewable tablet Compiled Order" max="1" path="/items" name="lamoTRIgine chewable tablet"/>
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71035f22-2277-4def-b27d-f5633a89e3f1" concept_name="PHARM lamoTRIgine tablet Compiled Order" max="1" path="/items" name="lamoTRIgine tablet"/>
            </Item>
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Weeks 3 and 4">
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d9629066-2292-4c1a-bf2f-18d81195dbc4" concept_name="PHARM lamoTRIgine chewable tablet Compiled Order" max="1" path="/items" name="lamoTRIgine chewable tablet"/>
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71035f22-2277-4def-b27d-f5633a89e3f1" concept_name="PHARM lamoTRIgine tablet Compiled Order" max="1" path="/items" name="lamoTRIgine tablet"/>
            </Item>
          </Item>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Maintenance Dose">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d9629066-2292-4c1a-bf2f-18d81195dbc4" concept_name="PHARM lamoTRIgine chewable tablet Compiled Order" max="1" path="/items" name="lamoTRIgine chewable tablet"/>
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71035f22-2277-4def-b27d-f5633a89e3f1" concept_name="PHARM lamoTRIgine tablet Compiled Order" max="1" path="/items" name="lamoTRIgine tablet"/>
          </Item>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Patients receiving antiseizure drug regimens containing valproic acid:">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Initiation:">
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Weeks 1 and 2">
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d9629066-2292-4c1a-bf2f-18d81195dbc4" concept_name="PHARM lamoTRIgine chewable tablet Compiled Order" max="1" path="/items" name="lamoTRIgine chewable tablet"/>
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71035f22-2277-4def-b27d-f5633a89e3f1" concept_name="PHARM lamoTRIgine tablet Compiled Order" max="1" path="/items" name="lamoTRIgine tablet"/>
            </Item>
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Weeks 3 and 4">
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d9629066-2292-4c1a-bf2f-18d81195dbc4" concept_name="PHARM lamoTRIgine chewable tablet Compiled Order" max="1" path="/items" name="lamoTRIgine chewable tablet"/>
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71035f22-2277-4def-b27d-f5633a89e3f1" concept_name="PHARM lamoTRIgine tablet Compiled Order" max="1" path="/items" name="lamoTRIgine tablet"/>
            </Item>
          </Item>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Maintenance dose">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d9629066-2292-4c1a-bf2f-18d81195dbc4" concept_name="PHARM lamoTRIgine chewable tablet Compiled Order" max="1" path="/items" name="lamoTRIgine chewable tablet"/>
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71035f22-2277-4def-b27d-f5633a89e3f1" concept_name="PHARM lamoTRIgine tablet Compiled Order" max="1" path="/items" name="lamoTRIgine tablet"/>
          </Item>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Patients receiving enzyme-inducing antiseizure drug regimens (eg, carbamazepine, phenytoin, phenobarbital, primidone) without valproic acid:">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Initiation:">
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Weeks 1 and 2">
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d9629066-2292-4c1a-bf2f-18d81195dbc4" concept_name="PHARM lamoTRIgine chewable tablet Compiled Order" max="1" path="/items" name="lamoTRIgine chewable tablet"/>
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71035f22-2277-4def-b27d-f5633a89e3f1" concept_name="PHARM lamoTRIgine tablet Compiled Order" max="1" path="/items" name="lamoTRIgine tablet"/>
            </Item>
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Weeks 3 and 4">
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d9629066-2292-4c1a-bf2f-18d81195dbc4" concept_name="PHARM lamoTRIgine chewable tablet Compiled Order" max="1" path="/items" name="lamoTRIgine chewable tablet"/>
              <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71035f22-2277-4def-b27d-f5633a89e3f1" concept_name="PHARM lamoTRIgine tablet Compiled Order" max="1" path="/items" name="lamoTRIgine tablet"/>
            </Item>
          </Item>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Maintenance dose">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d9629066-2292-4c1a-bf2f-18d81195dbc4" concept_name="PHARM lamoTRIgine chewable tablet Compiled Order" max="1" path="/items" name="lamoTRIgine chewable tablet"/>
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71035f22-2277-4def-b27d-f5633a89e3f1" concept_name="PHARM lamoTRIgine tablet Compiled Order" max="1" path="/items" name="lamoTRIgine tablet"/>
          </Item>
        </Item>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Adolescents (Greater than 12 Years Old)">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Patients receiving antiseizure drugs other than carbamazepine, phenytoin, phenobarbital, primidone, or valproic acid:">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Weeks 1 and 2">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71035f22-2277-4def-b27d-f5633a89e3f1" concept_name="PHARM lamoTRIgine tablet Compiled Order" max="1" path="/items" name="lamoTRIgine tablet"/>
          </Item>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Weeks 3 and 4">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71035f22-2277-4def-b27d-f5633a89e3f1" concept_name="PHARM lamoTRIgine tablet Compiled Order" max="1" path="/items" name="lamoTRIgine tablet"/>
          </Item>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Maintenance">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71035f22-2277-4def-b27d-f5633a89e3f1" concept_name="PHARM lamoTRIgine tablet Compiled Order" max="1" path="/items" name="lamoTRIgine tablet"/>
          </Item>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Patients receiving antiseizure drug regimens containing valproic acid:">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Weeks 1 and 2">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71035f22-2277-4def-b27d-f5633a89e3f1" concept_name="PHARM lamoTRIgine tablet Compiled Order" max="1" path="/items" name="lamoTRIgine tablet"/>
          </Item>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Weeks 3 and 4">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71035f22-2277-4def-b27d-f5633a89e3f1" concept_name="PHARM lamoTRIgine tablet Compiled Order" max="1" path="/items" name="lamoTRIgine tablet"/>
          </Item>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Maintenance">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71035f22-2277-4def-b27d-f5633a89e3f1" concept_name="PHARM lamoTRIgine tablet Compiled Order" max="1" path="/items" name="lamoTRIgine tablet"/>
          </Item>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Patients receiving enzyme-inducing antiseizure drug regimens (eg, carbamazepine, phenytoin, phenobarbital, primidone) without valproic acid:">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Weeks 1 and 2">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71035f22-2277-4def-b27d-f5633a89e3f1" concept_name="PHARM lamoTRIgine tablet Compiled Order" max="1" path="/items" name="lamoTRIgine tablet"/>
          </Item>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Weeks 3 and 4">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71035f22-2277-4def-b27d-f5633a89e3f1" concept_name="PHARM lamoTRIgine tablet Compiled Order" max="1" path="/items" name="lamoTRIgine tablet"/>
          </Item>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Maintenance">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="71035f22-2277-4def-b27d-f5633a89e3f1" concept_name="PHARM lamoTRIgine tablet Compiled Order" max="1" path="/items" name="lamoTRIgine tablet"/>
          </Item>
        </Item>
      </Item>
    </Item>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
</template>